Document Page: First | Prev | Next | All | Image | This Release | Search

File: 120396_mar96_decls7_0017.txt
Page: 0017
Total Pages: 17

Subject: DAILY STAFF JOURNAL 12 NOV 90                                   

Unit: XVIII CORPS 

Parent Organization: ARCENT      

Box ID: BX000036

Folder Title: DUTY LOG G3  EOC INCOMING MSGS  12 NOV 90                                                       

Document Number:          2

Folder SEQ  #:         34




                                                 UNCLASSIFIED



                     SIDE EFFECTS.    ORDINARILY, DISCONTINUING PYRIDOSTIGMINE SHOULD BE
                     ADEQUATE TO ALLEVIATE SIGNS/SYMPTOMS. PYRIDOSTIGMINE MAY PERSIST IN
                     THE BLOOD FOR 24 HOURS, HOWEVER, AFTER BLOOD LEVELS PEAK IN 4 HOURS,
                     EFFECTS DIMINISH GRADUALLY. EMERGENCY TREATMENT INCLUDES
                     ADMINISTERING ATROPINE IN DOSES SUFFICIENT TO OVERCOME THE
                     CHOLINERGIC CRISIS. USE OF THE 2-MG ATROPINE SHOULD BE ADMINISTERED
                     BY MEDICAL PERSONNEL EVERY FIFTEEN-TWENTY (15-20) MINUTES. SEVERE
                     CASES MAY REQUIRE ASSISTED VENTILATION BUT WOULD BE UNUSUAL IF THE
                     EIGHT HOUR ADMINISTERED DOSE HAD BEEN FOLLOWED. WHEN STABILIZED,
                     THE CASUALITY MAY NEED EVACUATION FOR FURTHER OBSERVATION AND
                     TREATMENT.




          PAGE 04 RUDCHAA0120
                     E.    (U) USE OF PYRIDOSTIBMINE PRETREATMENT IN AIRCREW PERSONNEL
                           1. AT DIRECTION OF COGNIZANT COMMANDER, ALL PERSONNEL INCLUDING
                     DESIGNATED AIRCREW WILL TAKE PYRIDOSTISMINE AS OUTLINED INPREVIOUS
                     PARAS.
                           2. AIRCREW MAY FLY IMMEDIATELY.
                           3. FLIGHT SURGEONS WILL CLOSELY MONITOR ALL AIRCREWS TAKING
                     PYRIDOSTIGMINE INCLUDING, AS FAR AS POSSIBLE, DAILY CONTACT WITH EACH
                     CREW MEMBER.
                           4.   FLIGHT SURGEONS AND AVIATION MEDICAL SAFETY OFFICERS SHOULD
                     BEGIN BRIEFING AIRCREWS ASAP CONCERNING USE AND POTENTIAL SIDE
                     EFFECTS OF PYRIDOSTIGMINE. EMPHASIS TO BE PLACED ON POTENTIAL
                     VISUAL IMPAIRMENT, PARTICULARLY AT NIGHT, AS WELL AS DECREASE IN HEAT
                     TOLERANCE.
                           5.   PRETESTING AVIATION PERSONNEL IS NOT REQUIRED TO DETERMINE
    ADVERSE EFFECTS.
                     F.    (U) RESPONSIBILITIES. LOWEST LEVEL CHAIN OF COMMAND WILL
                     DECIDE TO BEGIN, CONTINUE OR DISCONTINUE THE NAPP PRETREATMENT
                     MEDICATION BASED ON THREAT. INTELLIGENCE OFFICERS AND MEDICAL
                     PERSONNEL ACT AS ADVISORS TO THE COMMANDER IN MAKING HIS DECISION
                     IF A CHEMICAL THREAT EXISTS. AFTER THREE DAYS OF USING NAPP




           7-'AGE 05 RUDCHAA0120
                     COMMANDER AND STAFF SHOULD REEVALUATE COMBAT SITUATION TO DETERMINE
                     IF MEDICATION SHOULD BE CONTINUED OR DISCONTINUED. PRETREATMENT CAN
                     BEGIN AT ANY TIME DEPENDING ON THE SITUATION. IF PRETREATMENT IS
                     CONTINUED FOR SEVEN DAYS, AN ADDITIONAL NAPP MUST BE ISSUED AND
                     ADDITIONAL PACKS ORDERED. ADMINISTERING THE MEDICATION BEYOND
                     RECOMMENDED PERIOD OF 21 DAYS REQUIRES A THOROUGH EVALUATION OF
                     SITUATION.
                     5. (U) POTENTIAL RISK FOR ABUSE IS UNLIKELY. NAPP DOES NOT CREATE
                     A HIGH, EUPHORIC FEELING.
                     45. (U) NBC PI)C IS CPT WASDALT, COMM: 477-7777 EXT 3501, SURGEON
                     POC IS COL TSOULOS, ARCENT SURGEON, COMM: 477-7777 EXT 4075, TAC:
                     97664440.
                     DECL OARD
                     BT
                     #0120





                                               UNCLASSIFIED

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 17 f:/Week-10/BX000036/DUTY LOG G3 EOC INCOMING MSGS 12 NOV 90/daily staff journal 12 nov 90:11089615153056
Control Fields 17
File Room = mar96_declassified
File Cabinet = Week-10
Box ID = BX000036
Unit = XVIII CORPS
Parent Organization = ARCENT
Folder Title = DUTY LOG G3 EOC INCOMING MSGS 12 NOV 90
Folder Seq # = 34
Subject = DAILY STAFF JOURNAL 12 NOV 90
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996